Benitec Biopharma
BNTC
BNTC
6 hedge funds and large institutions have $190K invested in Benitec Biopharma in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
WS
1
Wedbush Securities
Los Angeles,
California
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Morgan Stanley
New York
| $61K | 20,700 | +20,700 | New |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $58K | 19,509 | +19,509 | New |
|
3
Renaissance Technologies
New York
| $41K | 13,700 | +13,700 | New |
|
4
UBS Group
Zurich,
Switzerland
| $13K | 4,443 | +85 | +2% |
|
5
CIBC Private Wealth Group
Atlanta,
Georgia
| $9K | 3,000 | +3,000 | New |
|
6
Bank of America
Charlotte,
North Carolina
| $8K | 2,600 | – | – |
|
|
WS
7
Wedbush Securities
Los Angeles,
California
| – | – | -18,197 | Closed |
|